Quarterly Review: New Technologies, Markets a Key Focus for Big Research Tools Firms
August 20, 2010
Quarterly Review: New Technologies, Markets a Key Focus for Big Research Tools Firms
As the current earnings season draws to a close, much of the talk from life science tool firms focused on the technologies they view as key revenue drivers now and going forward. Not surprisingly, sequencing, PCR, and mass spec were cited by the big research tool firms.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Personalized Medicine in 2012: Industry Takes a Wait-and-See Approach Due to Market Unknowns
January 9, 2013 / Pharmacogenomics Reporter - Mayo Clinic Assesses Target-Capture Options as Step Toward Sequencing-Based Molecular Diagnostics
July 13, 2010 / In Sequence - Short Reads
February 17, 2009 / In Sequence - Bankruptcy Court OKs Helicos' IP License Deals with Illumina, Life Tech, Fluidigm, Complete Genomics; Negotiations Ongoing with Roche
June 17, 2013 / GenomeWeb Daily News - New Desktop Sequencer Comparison Suggests 'Two-Horse Race' Between MiSeq, PGM
April 9, 2013 / In Sequence